MX9704824A - Adyuvantes para vacunas. - Google Patents
Adyuvantes para vacunas.Info
- Publication number
- MX9704824A MX9704824A MX9704824A MX9704824A MX9704824A MX 9704824 A MX9704824 A MX 9704824A MX 9704824 A MX9704824 A MX 9704824A MX 9704824 A MX9704824 A MX 9704824A MX 9704824 A MX9704824 A MX 9704824A
- Authority
- MX
- Mexico
- Prior art keywords
- adjuvants
- vaccine
- vaccine adjuvants
- sulpholipid
- polysaccharide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los adyuvantes para vacunas comprenden un polisacárido sulfolipídico en combinacion con un constituyente que forma una interfase. La invencion también proporciona un método para preparar una vacuna emulsificando una solucion acuosa de un antígeno y un polisacárido sulfolipídico. Los adyuvantes son estables a altas temperaturas y son al menos tan efectivos como los adyuvantes convencionales. su toxicidad local, es decir su reactogenicidad es generalmente más baja que la de los adyuvantes convencionales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9401174A BE1008978A5 (fr) | 1994-12-27 | 1994-12-27 | Adjuvants pour vaccins. |
BE9401174 | 1994-12-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9704824A true MX9704824A (es) | 1998-06-30 |
MXPA97004824A MXPA97004824A (es) | 1998-10-30 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3035941T3 (en) | Vaccine adjuvants | |
ATE410183T1 (de) | Verbesserte adjuvant zusammensetzungen auf basis von saponin und damit zusammenhängende methoden | |
DE69529684T2 (de) | Adjuvans für impfstoff | |
BG101995A (en) | Saponin and sterol-containing vaccines | |
ATE196737T1 (de) | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus | |
GB9817052D0 (en) | Vaccine | |
DK55891A (da) | Matrix med immunomodulerende virkning | |
BR9106205A (pt) | Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento | |
NO932102D0 (no) | Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen | |
ES2044849T3 (es) | Un procedimiento para preparar un glicosido de flavona. | |
OA09800A (en) | Vaccine compositions containing liposomes. | |
NL300404I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
DK0876398T3 (da) | Induktion af immunrespons med ønskede determinanter | |
GR3031487T3 (en) | Pasteurella multocida toxoid vaccines. | |
EP0547102A4 (es) | ||
BG96682A (bg) | Метод за получаване на циклохексанови и тетрахидропиранови производни | |
HUP9801917A2 (hu) | Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására | |
GR3019525T3 (en) | Neuraminidase and galactose oxidase as vaccine adjuvant | |
GB9303681D0 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status |